Current and Emerging Applications of Droplet Digital PCR in Oncology: An Updated Review

[1]  G. Garcia-Manero,et al.  Autologous CD33-CAR-T cells for treatment of relapsed/refractory acute myelogenous leukemia , 2021, Leukemia.

[2]  D. Schadendorf,et al.  Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib: a clinical validation study. , 2021, The Lancet. Oncology.

[3]  Xiuhua Jia,et al.  TMEM2 binds to CSNK2A3 to inhibit HBV infection via activation of the JAK/STAT pathway. , 2021, Experimental cell research.

[4]  V. Conteduca,et al.  Androgen receptor gain in circulating free DNA and splicing variant 7 in exosomes predict clinical outcome in CRPC patients treated with abiraterone and enzalutamide , 2021, Prostate cancer and prostatic diseases.

[5]  M. Ishida,et al.  MicroRNA-593-3p Expression in Peritoneal Lavage Fluid as a Prognostic Marker for Pancreatic Cancer Patients Undergoing Staging Laparoscopy , 2021, Annals of Surgical Oncology.

[6]  O. Burghuber,et al.  Detection of EGFR Activating and Resistance Mutations by Droplet Digital PCR in Sputum of EGFR-Mutated NSCLC Patients , 2021, Clinical Medicine Insights. Oncology.

[7]  Irene L. Ch’en,et al.  Monitoring of tisagenlecleucel transgene DNA using a quantitative polymerase chain reaction assay , 2020, Molecular therapy. Methods & clinical development.

[8]  Y. Miyagi,et al.  Detection of EGFR mutation of pulmonary adenocarcinoma in sputum using droplet digital PCR , 2020, BMC Pulmonary Medicine.

[9]  M. Boerries,et al.  Longitudinal analysis of cell-free mutated KRAS and CA 19–9 predicts survival following curative resection of pancreatic cancer , 2020, BMC Cancer.

[10]  A. Mallory,et al.  6-Color Crystal Digital PCRTM for the High-Plex Detection of EGFR Mutations in Non-Small Cell Lung Cancer. , 2021, Methods in molecular biology.

[11]  S. Indraccolo,et al.  Detection of Low-Frequency KRAS Mutations in cfDNA From EGFR-Mutated NSCLC Patients After First-Line EGFR Tyrosine Kinase Inhibitors , 2021, Frontiers in Oncology.

[12]  J. Kim,et al.  Serum-Based KRASG12/G13 Mutation Detection Using Droplet Digital PCR: Clinical Implications and Limitations in Colorectal Adenocarcinoma With Tumor Heterogeneity , 2021, Frontiers in Oncology.

[13]  W. Knoefel,et al.  Bile-Based Cell-Free DNA Analysis Is a Reliable Diagnostic Tool in Pancreatobiliary Cancer , 2020, Cancers.

[14]  D. García-Olmo,et al.  Liquid biopsy in peritoneal fluid and plasma as a prognostic factor in advanced colorectal and appendiceal tumors after complete cytoreduction and hyperthermic intraperitoneal chemotherapy , 2020, Therapeutic advances in medical oncology.

[15]  C. Porta,et al.  A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC , 2020, Cancer Immunology, Immunotherapy.

[16]  Manuela Cattelan,et al.  Circulating miR-26a as Potential Prognostic Biomarkers in Pediatric Rhabdomyosarcoma , 2020, Frontiers in Genetics.

[17]  N. Hayward,et al.  The Prognostic Impact of Circulating Tumour DNA in Melanoma Patients Treated with Systemic Therapies—Beyond BRAF Mutant Detection , 2020, Cancers.

[18]  A. Hinke,et al.  Serial Circulating Tumor DNA Mutational Status in Patients with KRAS-Mutant Metastatic Colorectal Cancer from the Phase 3 AIO KRK0207 Trial. , 2020, Clinical chemistry.

[19]  S. Soverini,et al.  Molecular Testing in CML between Old and New Methods: Are We at a Turning Point? , 2020, Journal of clinical medicine.

[20]  G. Byrnes,et al.  Development of Sensitive Droplet Digital PCR Assays for Detecting Urinary TERT Promoter Mutations as Non-Invasive Biomarkers for Detection of Urothelial Cancer , 2020, Cancers.

[21]  K. Hattori,et al.  Monitoring of MYD88 L265P mutation by droplet digital polymerase chain reaction for prediction of early relapse in a patient with Bing–Neel syndrome , 2020, International Journal of Hematology.

[22]  V. Mikhailovich,et al.  Microarray-based analysis of the BRAF V600 mutations in circulating tumor DNA in melanoma patients. , 2020, Cancer genetics.

[23]  K. Weinfurt,et al.  Assessment of Outcomes After Stopping Tyrosine Kinase Inhibitors Among Patients With Chronic Myeloid Leukemia: A Nonrandomized Clinical Trial. , 2020, JAMA oncology.

[24]  M. Millward,et al.  Stopping targeted therapy for complete responders in advanced BRAF mutant melanoma , 2020, Scientific Reports.

[25]  Shinya Takahashi,et al.  Clinical Implications of Pre- and Postoperative Circulating Tumor DNA in Patients with Resected Pancreatic Ductal Adenocarcinoma , 2020, Annals of Surgical Oncology.

[26]  X. Puente,et al.  Circulating tumour DNA from the cerebrospinal fluid allows the characterisation and monitoring of medulloblastoma , 2020, Nature Communications.

[27]  P. Robertson,et al.  Electronic DNA Analysis of CSF Cell-free Tumor DNA to Quantify Multi-gene Molecular Response in Pediatric High-grade Glioma , 2020, Clinical Cancer Research.

[28]  L. Strigari,et al.  Combined molecular and mathematical analysis of long noncoding RNAs expression in fine needle aspiration biopsies as novel tool for early diagnosis of thyroid cancer , 2020, Endocrine.

[29]  J. Chiaroni,et al.  Evaluation of next-generation sequencing and Crystal Digital PCR™ for chimerism monitoring of post-allogeneic haematopoietic stem cell transplantation. , 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[30]  E. Scarpi,et al.  Plasma AR Copy Number Changes and Outcome to Abiraterone and Enzalutamide , 2020, Frontiers in Oncology.

[31]  F. Puglisi,et al.  Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer , 2020, Frontiers in Oncology.

[32]  J. Tong,et al.  A Protocol for Cancer-Related Mutation Detection on Exosomal DNA in Clinical Application , 2020, Frontiers in Oncology.

[33]  H. Tseng,et al.  Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring , 2020, Nature Communications.

[34]  A. Robidoux,et al.  Prognostic and predictive value of circulating tumor DNA during neoadjuvant chemotherapy for triple negative breast cancer , 2020, Scientific Reports.

[35]  P. Sillero,et al.  Comparison of Droplet Digital PCR versus qPCR Measurements on the International Scale for the Molecular Monitoring of Chronic Myeloid Leukemia Patients , 2020, Molecular Diagnosis & Therapy.

[36]  F. Sonohara,et al.  Peritoneal Lavage Tumor DNA as a Novel Biomarker for Predicting Peritoneal Recurrence in Pancreatic Ductal Adenocarcinoma , 2020, Annals of Surgical Oncology.

[37]  S. Srivastava,et al.  A Urine Exosome Gene Expression Panel Distinguishes Between Indolent and Aggressive Prostate Cancers at Biopsy. , 2020, The Journal of urology.

[38]  R. Kučera,et al.  The Level of Preoperative Plasma KRAS Mutations and CEA Predict Survival of Patients Undergoing Surgery for Colorectal Cancer Liver Metastases , 2020, Cancers.

[39]  C. Scapoli,et al.  A Distinctive microRNA (miRNA) Signature in the Blood of Colorectal Cancer (CRC) Patients at Surgery , 2020, Cancers.

[40]  R. Foà,et al.  Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma , 2020, Hematological oncology.

[41]  Xiaoling Zhang,et al.  Plasma-based early screening and monitoring of EGFR mutations in NSCLC patients by a 3-color digital PCR assay , 2020, British Journal of Cancer.

[42]  J. Duyster,et al.  Personalized Treatment Selection and Disease Monitoring Using Circulating Tumor DNA Profiling in Real-World Cancer Patient Management , 2020, Diagnostics.

[43]  Jim F Huggett,et al.  The Digital MIQE Guidelines Update: Minimum Information for Publication of Quantitative Digital PCR Experiments for 2020. , 2020, Clinical chemistry.

[44]  L. Goh,et al.  Clinical implementation of plasma EGFR T790M testing using droplet digital PCR in TKI-resistant NSCLC patients. , 2020, Experimental and molecular pathology.

[45]  K. Margiotti,et al.  Quantification of circulating microRNAs by droplet digital PCR for cancer detection , 2020, BMC Research Notes.

[46]  O. Fletcher,et al.  DNA methylation of the long intergenic noncoding RNA 299 gene in triple-negative breast cancer: results from a prospective study , 2020, Scientific Reports.

[47]  Yuying Zhang,et al.  Comparison of the Clinical Validity of Droplet Digital PCR to ARMS‐PCR for BRAF V600E Mutation Detection in Thyroid Nodules , 2020, Journal of clinical laboratory analysis.

[48]  E. Shumilov,et al.  Analysis of IL-6 serum levels and CAR-T cell specific digital PCR in the context of cytokine release syndrome (CRS). , 2020, Experimental hematology.

[49]  Ann M. Miller,et al.  Peritoneal Cell-Free Tumor DNA as Biomarker for Peritoneal Surface Malignancies , 2020, Annals of Surgical Oncology.

[50]  N. Kröger,et al.  Accurate In-Vivo Quantification of CD19 CAR-T Cells after Treatment with Axicabtagene Ciloleucel (Axi-Cel) and Tisagenlecleucel (Tisa-Cel) Using Digital PCR , 2020, Cancers.

[51]  U. Keilholz,et al.  Analysis of cancer-related mutations in extracellular vesicles RNA by Droplet Digital™ PCR. , 2020, BioTechniques.

[52]  S. Deng,et al.  A Novel lncRNA NONHSAT053785 Acts as an Independent Risk Factor for Intrahepatic Metastasis of Hepatocellular Carcinoma , 2020, OncoTargets and therapy.

[53]  A. Casadei‐Gardini,et al.  Colorectal Cancer Early Detection in Stool Samples Tracing CpG Islands Methylation Alterations Affecting Gene Expression , 2020, International journal of molecular sciences.

[54]  H. Guadalajara,et al.  The role of mucin cell-free DNA detection as a new marker for the study of acellular pseudomyxoma peritonei of appendicular origin by liquid biopsy , 2020, Therapeutic advances in medical oncology.

[55]  G. Kazemier,et al.  Circulating Tumor DNA as a Preoperative Marker of Recurrence in Patients with Peritoneal Metastases of Colorectal Cancer: A Clinical Feasibility Study , 2020, Journal of clinical medicine.

[56]  K. D. Sørensen,et al.  Epigenetic Analysis of Circulating Tumor DNA in Localized and Metastatic Prostate Cancer: Evaluation of Clinical Biomarker Potential , 2020, Cells.

[57]  W. Kim,et al.  A novel urinary mRNA signature using the droplet digital polymerase chain reaction platform improves discrimination between prostate cancer and benign prostatic hyperplasia within the prostate-specific antigen gray zone , 2020, Investigative and clinical urology.

[58]  F. Shepherd,et al.  Clinical implementation of circulating tumour DNA testing for EGFR T790M for detection of treatment resistance in non-small cell lung cancer , 2020, Journal of Clinical Pathology.

[59]  S. Sabbioni,et al.  Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer , 2020, Molecular oncology.

[60]  L. Saal,et al.  Subclonal patterns in follow-up of acute myeloid leukemia combining whole exome sequencing and ultrasensitive IBSAFE digital droplet analysis , 2020, Leukemia & lymphoma.

[61]  G. Netto,et al.  Clinical Significance of Hotspot Mutation Analysis of Urinary Cell-Free DNA in Urothelial Bladder Cancer , 2020, Frontiers in Oncology.

[62]  A. Maghnouj,et al.  Digital-Droplet PCR for Quantification of CD19-Directed CAR T-Cells , 2020, Frontiers in Molecular Biosciences.

[63]  G. Kazemier,et al.  Circulating tumor DNA analysis of EGFR-mutant non-small cell lung cancer patients receiving osimertinib following previous tyrosine kinase inhibitor treatment. , 2020, Lung cancer.

[64]  G. Kang,et al.  Liquid biopsy-based tumor profiling for metastatic colorectal cancer patients with ultra-deep targeted sequencing , 2020, PloS one.

[65]  K. Hasegawa,et al.  Evaluation of Circulating Tumor DNA in Patients with Ovarian Cancer Harboring Somatic PIK3CA or KRAS Mutations , 2020, Cancer research and treatment : official journal of Korean Cancer Association.

[66]  J. Lindebjerg,et al.  Early identification of treatment benefit by methylated circulating tumor DNA in metastatic colorectal cancer , 2020, Therapeutic advances in medical oncology.

[67]  V. Quillien,et al.  58P Detection of PIK3CA mutations in plasma ctDNA by Crystal Digital PCR for the selection of alpelisib treatment in routine clinical practice in advanced breast cancer patients , 2020 .

[68]  D. Cilloni,et al.  Novel Multiplex Droplet Digital PCR Assays to Monitor Minimal Residual Disease in Chronic Myeloid Leukemia Patients Showing Atypical BCR-ABL1 Transcripts , 2020, Journal of clinical medicine.

[69]  M. Guan,et al.  Effectiveness of digital PCR for MYD88L265P detection in vitreous fluid for primary central nervous system lymphoma diagnosis , 2020, Experimental and therapeutic medicine.

[70]  D. Issadore,et al.  A Multianalyte Panel Consisting of Extracellular Vesicle miRNAs and mRNAs, cfDNA, and CA19-9 Shows Utility for Diagnosis and Staging of Pancreatic Ductal Adenocarcinoma , 2020, Clinical Cancer Research.

[71]  E. Macintyre,et al.  Droplet Digital PCR Quantification of Mantle Cell Lymphoma Follow-up Samples From Four Prospective Trials of the European MCL Network , 2020, HemaSphere.

[72]  D. Stroncek,et al.  Application of droplet digital PCR for the detection of vector copy number in clinical CAR/TCR T cell products , 2020, Journal of Translational Medicine.

[73]  K. Kaczka,et al.  Analysis of Let-7 Family miRNA in Plasma as Potential Predictive Biomarkers of Diagnosis for Papillary Thyroid Cancer , 2020, Diagnostics.

[74]  F. Bosch,et al.  Cell free circulating tumor DNA in cerebrospinal fluid detects and monitors central nervous system involvement of B-cell lymphomas , 2020, Haematologica.

[75]  J. Esteve,et al.  Application of a digital PCR method for WT1 to myeloid neoplasms in CR and deep ELN WT1 molecular response (< 10 copies) , 2020, Annals of Hematology.

[76]  Y. Chang,et al.  Compared to plasma, bronchial washing fluid shows higher diagnostic yields for detecting EGFR-TKI sensitizing mutations by ddPCR in lung cancer , 2020, Respiratory Research.

[77]  M. Stern,et al.  High-Accuracy Determination of Microsatellite Instability Compatible with Liquid Biopsies. , 2020, Clinical chemistry.

[78]  R. Malekzadeh,et al.  Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study , 2020, EBioMedicine.

[79]  James B. Freeman,et al.  Detection and prognostic role of heterogeneous populations of melanoma circulating tumour cells , 2020, British Journal of Cancer.

[80]  P. Rutkowski,et al.  Cell-free DNA BRAF V600E measurements during BRAF inhibitor therapy of metastatic melanoma: long-term analysis , 2020, Tumori.

[81]  J. Fletcher,et al.  Clinical value of next generation sequencing of plasma cell-free DNA in gastrointestinal stromal tumors , 2020, BMC Cancer.

[82]  A. Fontana,et al.  Clinical Significance of Circulating miR-1273g-3p and miR-122-5p in Pancreatic Cancer , 2020, Frontiers in Oncology.

[83]  N. Normanno,et al.  Targeted sequencing analysis of cell-free DNA from metastatic non-small-cell lung cancer patients: clinical and biological implications , 2020, Translational lung cancer research.

[84]  A. Urruticoechea,et al.  The Urinary Transcriptome as a Source of Biomarkers for Prostate Cancer , 2020, Cancers.

[85]  A. Patiño-García,et al.  RNU6-1 in circulating exosomes differentiates GBM from non-neoplastic brain lesions and PCNSL but not from brain metastases , 2020, Neuro-oncology advances.

[86]  Liping Zhang,et al.  Comparison of the SuperARMS and ARMS for detecting EGFR mutations in liquid-based cytology specimens from NSCLC patients , 2020, Diagnostic Pathology.

[87]  N. Kröger,et al.  Digital PCR Assays for Precise Quantification of CD19-CAR-T Cells after Treatment with Axicabtagene Ciloleucel , 2020, Molecular therapy. Methods & clinical development.

[88]  Lianhua Dong,et al.  Interlaboratory assessment of droplet digital PCR for quantification of BRAF V600E mutation using a novel DNA reference material. , 2020, Talanta.

[89]  J. Schellens,et al.  Circulating epithelial tumor cell analysis in CSF in patients with leptomeningeal metastases , 2020, Neurology.

[90]  S. Horiguchi,et al.  Evaluation of Local Recurrence of Pancreatic Cancer by KRAS Mutation Analysis Using Washes from Endoscopic Ultrasound-Guided Fine-Needle Aspiration , 2020, Digestive Diseases and Sciences.

[91]  N. Wang,et al.  Anti-CD30 chimeric antigen receptor T cell therapy for relapsed/refractory CD30+ lymphoma patients , 2020, Blood Cancer Journal.

[92]  D. Cilloni,et al.  Highly Sensitive Detection of IDH2 Mutations in Acute Myeloid Leukemia , 2020, Journal of clinical medicine.

[93]  C. Bettegowda,et al.  Liquid biopsy for pediatric diffuse midline glioma: a review of circulating tumor DNA and cerebrospinal fluid tumor DNA. , 2020, Neurosurgical focus.

[94]  M. Hur,et al.  Performance Evaluation of the QXDx BCR-ABL %IS Droplet Digital PCR Assay , 2019, Annals of laboratory medicine.

[95]  J. Malvehy,et al.  Detection of cell‐free circulating BRAFV600E by droplet digital polymerase chain reaction in patients with and without melanoma under dermatological surveillance , 2020, The British journal of dermatology.

[96]  T. Rikiyama,et al.  Longitudinal monitoring of KRAS-mutated circulating tumor DNA enables the prediction of prognosis and therapeutic responses in patients with pancreatic cancer , 2019, PloS one.

[97]  M. Rusan,et al.  Circulating HOXA9-methylated tumour DNA: A novel biomarker of response to poly (ADP-ribose) polymerase inhibition in BRCA-mutated epithelial ovarian cancer. , 2019, European journal of cancer.

[98]  T. Huang,et al.  Acoustofluidic Salivary Exosome Isolation: A Liquid Biopsy Compatible Approach for Human Papillomavirus-Associated Oropharyngeal Cancer Detection. , 2019, The Journal of molecular diagnostics : JMD.

[99]  Noriyuki Nishimura,et al.  Level of seven neuroblastoma-associated mRNAs detected by droplet digital PCR is associated with tumor relapse/regrowth of high-risk neuroblastoma patients. , 2019, The Journal of molecular diagnostics : JMD.

[100]  I. Wistuba,et al.  TMPRSS4: A Novel Tumor Prognostic Indicator for the Stratification of Stage IA Tumors and a Liquid Biopsy Biomarker for NSCLC Patients , 2019, Journal of clinical medicine.

[101]  M. Borowiec,et al.  Usefulness of droplet digital PCR and Sanger sequencing for detection of FGFR3 mutation in bladder cancer. , 2019, Urologic oncology.

[102]  R. Foà,et al.  Digital droplet PCR at the time of TKI discontinuation in chronic‐phase chronic myeloid leukemia patients is predictive of treatment‐free remission outcome , 2019, Hematological Oncology.

[103]  Jian-Hua Tong,et al.  KRAS Mutant Allele Fraction in Circulating Cell-Free DNA Correlates With Clinical Stage in Pancreatic Cancer Patients , 2019, Front. Oncol..

[104]  J. Nielsen,et al.  The Translational Status of Cancer Liquid Biopsies , 2019, Regenerative Engineering and Translational Medicine.

[105]  H. Nielsen,et al.  Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer—a clinical biomarker discovery and validation study , 2019, Clinical Epigenetics.

[106]  A. Bardelli,et al.  Whole exome sequencing analysis of urine trans-renal tumour DNA in metastatic colorectal cancer patients , 2019, ESMO Open.

[107]  J. Cheong,et al.  Use of Droplet Digital Polymerase Chain Reaction for Detecting Minimal Residual Disease: A Prospective Multi-Institutional Study , 2019, In Vivo.

[108]  H. Leong,et al.  Plasma extracellular vesicles as phenotypic biomarkers in prostate cancer patients , 2019, The Prostate.

[109]  I. Hedenfalk,et al.  Detecting TP53 mutations in diagnostic and archival liquid-based Pap samples from ovarian cancer patients using an ultra-sensitive ddPCR method , 2019, Scientific Reports.

[110]  C. Vanderburg,et al.  Identification of Circulating Serum Multi-MicroRNA Signatures in Human DLBCL Models , 2019, Scientific Reports.

[111]  S. Dabernat,et al.  High Clinical Value of Liquid Biopsy to Detect Circulating Tumor Cells and Tumor Exosomes in Pancreatic Ductal Adenocarcinoma Patients Eligible for Up-Front Surgery , 2019, Cancers.

[112]  Xianjin Zhou,et al.  Clinical Relevance of the High Prevalence of MYD88 L265P Mutated Vitreoretinal Lymphoma Identified by Droplet Digital Polymerase Chain Reaction , 2019, Ocular immunology and inflammation.

[113]  M. Iddawela,et al.  Circulating oestrogen receptor mutations and splice variants in advanced prostate cancer , 2019, BJU international.

[114]  P. Laurent-Puig,et al.  Plasma clearance of RAS mutation under therapeutic pressure is a rare event in metastatic colorectal cancer , 2019, International journal of cancer.

[115]  R. Foà,et al.  Minimal residual disease (MRD) in non‐Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD Network , 2019, Hematological oncology.

[116]  M. Eisenacher,et al.  Digital droplet PCR‐based chimerism analysis for monitoring of hematopoietic engraftment after allogeneic stem cell transplantation , 2019, International journal of laboratory hematology.

[117]  G. Santoni,et al.  Expression Profiling of Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma Patients: Biomarkers Predicting Overall Survival , 2019, Front. Oncol..

[118]  Victor M. Lu,et al.  Liquid biopsy for diffuse intrinsic pontine glioma: an update. , 2019, Journal of neurosurgery. Pediatrics.

[119]  C. Paweletz,et al.  Phase I Study of Rapid Alternation of Sunitinib and Regorafenib for the Treatment of Tyrosine Kinase Inhibitor Refractory Gastrointestinal Stromal Tumors , 2019, Clinical Cancer Research.

[120]  C. Andersen,et al.  Correlation between early dynamics in circulating tumour DNA and outcome from FOLFIRI treatment in metastatic colorectal cancer , 2019, Scientific Reports.

[121]  P. Ding,et al.  The predictive and prognostic significance of liquid biopsy in advanced epidermal growth factor receptor-mutated non-small cell lung cancer: A prospective study. , 2019, Lung cancer.

[122]  C. Paweletz,et al.  Salivary HPV DNA informs locoregional disease status in advanced HPV-associated oropharyngeal cancer. , 2019, Oral oncology.

[123]  R. Danesi,et al.  Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients , 2019, Breast Cancer Research and Treatment.

[124]  T. Fahey,et al.  Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy , 2019, Scientific Reports.

[125]  S. Horiguchi,et al.  Utility of liquid biopsy using urine in patients with pancreatic ductal adenocarcinoma , 2019, Cancer biology & therapy.

[126]  G. Romieu,et al.  PIK3CA mutations early persistence in cell-free tumor DNA as a negative prognostic factor in metastatic breast cancer patients treated with hormonal therapy , 2019, Breast Cancer Research and Treatment.

[127]  P. Cony-Makhoul,et al.  Evaluation of Residual Disease and TKI Duration Are Critical Predictive Factors for Molecular Recurrence after Stopping Imatinib First-line in Chronic Phase CML Patients , 2019, Clinical Cancer Research.

[128]  K. Spindler,et al.  Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[129]  T. Becker,et al.  Detection of AR-V7 in Liquid Biopsies of Castrate Resistant Prostate Cancer Patients: A Comparison of AR-V7 Analysis in Circulating Tumor Cells, Circulating Tumor RNA and Exosomes , 2019, Cells.

[130]  E. Scarpi,et al.  Plasma AR status and cabazitaxel in heavily treated metastatic castration-resistant prostate cancer. , 2019, European journal of cancer.

[131]  L. Saal,et al.  Detection of circulating tumor cells and circulating tumor DNA before and after mammographic breast compression in a cohort of breast cancer patients scheduled for neoadjuvant treatment , 2019, Breast Cancer Research and Treatment.

[132]  L. Saal,et al.  Pre-operative plasma cell-free circulating tumor DNA and serum protein tumor markers as predictors of lung adenocarcinoma recurrence , 2019, Acta oncologica.

[133]  Maoshan Chen,et al.  Utility of Circulating Cell-Free RNA Analysis for the Characterization of Global Transcriptome Profiles of Multiple Myeloma Patients , 2019, Cancers.

[134]  M. Guan,et al.  Digital PCR-Based Detection of EGFR Mutations in Paired Plasma and CSF Samples of Lung Adenocarcinoma Patients with Central Nervous System Metastases , 2019, Targeted Oncology.

[135]  I. Wistuba,et al.  Liquid Biopsy Assay for Lung Carcinoma Using Centrifuged Supernatants from Fine Needle Aspiration Specimens. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[136]  Lisa M Haley,et al.  Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer , 2019, Clinical Cancer Research.

[137]  H. Do,et al.  Standard dose osimertinib for erlotinib refractory T790M-negative EGFR-mutant non-small cell lung cancer with leptomeningeal disease. , 2019, Journal of thoracic disease.

[138]  M. Ychou,et al.  Circulating Tumor Cells and Circulating Tumor DNA Detection in Potentially Resectable Metastatic Colorectal Cancer: A Prospective Ancillary Study to the Unicancer Prodige-14 Trial , 2019, Cells.

[139]  M. Metzler,et al.  Large amplicon droplet digital PCR for DNA‐based monitoring of pediatric chronic myeloid leukaemia , 2019, Journal of cellular and molecular medicine.

[140]  S. Dawson,et al.  Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNA. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[141]  J. Duyster,et al.  Droplet digital PCR for the simultaneous analysis of minimal residual disease and hematopoietic chimerism after allogeneic cell transplantation , 2019, Clinical chemistry and laboratory medicine.

[142]  P. Wimberger,et al.  Clinical relevance of circulating MACC1 and S100A4 transcripts for ovarian cancer , 2019, Molecular oncology.

[143]  G. Netto,et al.  Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell‐free DNA in upper tract urothelial carcinoma , 2019, Cancer science.

[144]  M. Guan,et al.  Detection of BRAF V600E mutation in fine-needle aspiration fluid of papillary thyroid carcinoma by droplet digital PCR. , 2019, Clinica chimica acta; international journal of clinical chemistry.

[145]  I. Kozarewa,et al.  Early ctDNA dynamics as a surrogate for progression-free survival in advanced breast cancer in the BEECH trial , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[146]  E. Scarpi,et al.  Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer , 2019, European urology.

[147]  I. Wistuba,et al.  Centrifuged supernatants from FNA provide a liquid biopsy option for clinical next‐generation sequencing of thyroid nodules , 2019, Cancer cytopathology.

[148]  P. Nederlof,et al.  Cell-free DNA in the supernatant of pleural effusion can be used to detect driver and resistance mutations, and can guide tyrosine kinase inhibitor treatment decisions , 2019, ERJ Open Research.

[149]  G. Favre,et al.  Early Circulating Tumour DNA Variations Predict Tumour Response in Melanoma Patients Treated with Immunotherapy. , 2019, Acta dermato-venereologica.

[150]  A. Vincent-Salomon,et al.  A single droplet digital PCR for ESR1 activating mutations detection in plasma , 2019, bioRxiv.

[151]  Mei Liu,et al.  Urinary and Plasma Cell‐Free DNA Comparison for Lung Cancer Patients Treated With Epidermal Growth Factor Receptor—Thyroxine Kinase Inhibitors , 2019, The American journal of the medical sciences.

[152]  A. Maitra,et al.  Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer. , 2019, Gastroenterology.

[153]  M. Huibers,et al.  MYD88 p.(L265P) detection on cell‐free DNA in liquid biopsies of patients with primary central nervous system lymphoma , 2018, British journal of haematology.

[154]  Martin C. Müller,et al.  Comparison of Real-Time quantitative PCR and digital droplet PCR for BCR-ABL1 Monitoring in Patients with Chronic Myeloid Leukemia. , 2020, The Journal of molecular diagnostics : JMD.

[155]  K. Nishio,et al.  Longitudinal monitoring of somatic genetic alterations in circulating cell‐free DNA during treatment with epidermal growth factor receptor–tyrosine kinase inhibitors , 2019, Cancer.

[156]  G. Mills,et al.  Detection of breast cancer stem cell gene mutations in circulating free DNA during the evolution of metastases , 2019, Breast Cancer Research and Treatment.

[157]  L. Lacroix,et al.  EGFR C797S, EGFR T790M and EGFR sensitizing mutations in non-small cell lung cancer revealed by six-color crystal digital PCR , 2018, Oncotarget.

[158]  L. Anelli,et al.  Droplet digital PCR for the quantification of Alu methylation status in hematological malignancies , 2018, Diagnostic Pathology.

[159]  A. Chella,et al.  The amount of activating EGFR mutations in circulating cell-free DNA is a marker to monitor osimertinib response , 2018, British Journal of Cancer.

[160]  A. Andriulli,et al.  Droplet digital PCR quantification of miR-1290 as a circulating biomarker for pancreatic cancer , 2018, Scientific Reports.

[161]  K. Spindler,et al.  Total cell-free DNA, carcinoembryonic antigen, and C-reactive protein for assessment of prognosis in patients with metastatic colorectal cancer , 2018, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[162]  V. Carlton,et al.  A comparison of minimal residual disease detection in autografts among ASO‐qPCR, droplet digital PCR, and next‐generation sequencing in patients with multiple myeloma who underwent autologous stem cell transplantation , 2018, British journal of haematology.

[163]  Ao Li,et al.  High Sensitive and Non-invasive ctDNAs Sequencing Facilitate Clinical Diagnosis And Clinical Guidance of Non-small Cell Lung Cancer Patient: A Time Course Study , 2018, Front. Oncol..

[164]  Winnie S. Liang,et al.  Clinically Relevant and Minimally Invasive Tumor Surveillance of Pediatric Diffuse Midline Gliomas Using Patient-Derived Liquid Biopsy , 2018, Clinical Cancer Research.

[165]  F. Saad,et al.  Expression of AR-V7 and ARv567es in Circulating Tumor Cells Correlates with Outcomes to Taxane Therapy in Men with Metastatic Prostate Cancer Treated in TAXYNERGY , 2018, Clinical Cancer Research.

[166]  M. Huibers,et al.  Potential Diagnosis of Vitreoretinal Lymphoma by Detection of MYD88 Mutation in Aqueous Humor With Ultrasensitive Droplet Digital Polymerase Chain Reaction , 2018, JAMA ophthalmology.

[167]  D. O’Connell,et al.  Analytic and clinical validity of thyroid nodule mutational profiling using droplet digital polymerase chain reaction , 2018, Journal of Otolaryngology - Head & Neck Surgery.

[168]  Jay-Jiguang Zhu,et al.  Detection of the MYD88 p.L265P Mutation in the CSF of a Patient With Secondary Central Nervous System Lymphoma , 2018, Front. Oncol..

[169]  C. Paweletz,et al.  Plasma HPV cell-free DNA monitoring in advanced HPV-associated oropharyngeal cancer , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[170]  J. L. Costa,et al.  Multicenter Evaluation of the Idylla NRAS-BRAF Mutation Test in Metastatic Colorectal Cancer. , 2018, The Journal of molecular diagnostics : JMD.

[171]  George D. Cresswell,et al.  Somatic TP53 Mutations Are Detectable in Circulating Tumor DNA from Children with Anaplastic Wilms Tumors , 2018, Translational oncology.

[172]  P. Robertson,et al.  CSF H3F3A K27M circulating tumor DNA copy number quantifies tumor growth and in vitro treatment response , 2018, Acta Neuropathologica Communications.

[173]  M. Zhan,et al.  A Plasma Long Noncoding RNA Signature for Early Detection of Lung Cancer , 2018, Translational oncology.

[174]  C. Paweletz,et al.  Liquid biopsy of fine-needle aspiration supernatant for lung cancer genotyping. , 2018, Lung cancer.

[175]  Peiyong Jiang,et al.  Liver- and Colon-Specific DNA Methylation Markers in Plasma for Investigation of Colorectal Cancers with or without Liver Metastases. , 2018, Clinical chemistry.

[176]  C. Demuth,et al.  A method for treatment monitoring using circulating tumour DNA in cancer patients without targetable mutations , 2018, Oncotarget.

[177]  Yan-hong Tan,et al.  Droplet digital PCR for BCR/ABL(P210) detection of chronic myeloid leukemia: A high sensitive method of the minimal residual disease and disease progression , 2018, European journal of haematology.

[178]  L. Anelli,et al.  Droplet Digital PCR Is a Robust Tool for Monitoring Minimal Residual Disease in Adult Philadelphia-Positive Acute Lymphoblastic Leukemia. , 2018, The Journal of molecular diagnostics : JMD.

[179]  S. Miyano,et al.  Circulating tumor DNA dynamically predicts response and/or relapse in patients with hematological malignancies , 2018, International Journal of Hematology.

[180]  Yongjun Guo,et al.  Droplet Digital PCR-Based Detection of Clarithromycin Resistance in Helicobacter pylori Isolates Reveals Frequent Heteroresistance , 2018, Journal of Clinical Microbiology.

[181]  J. Huse,et al.  Evaluating Circulating Tumor DNA From the Cerebrospinal Fluid of Patients With Melanoma and Leptomeningeal Disease , 2018, Journal of neuropathology and experimental neurology.

[182]  P. Laurent-Puig,et al.  Mutation and Methylation Analysis of Circulating Tumor DNA Can Be Used for Follow‐up of Metastatic Colorectal Cancer Patients , 2018, Clinical colorectal cancer.

[183]  Peter Schenk,et al.  Cell‐Free Plasma DNA‐Guided Treatment With Osimertinib in Patients With Advanced EGFR‐Mutated NSCLC , 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[184]  G. Behre,et al.  Digital droplet PCR-based absolute quantification of pre-transplant NPM1 mutation burden predicts relapse in acute myeloid leukemia patients , 2018, Annals of Hematology.

[185]  Hong-Bin Fang,et al.  An epigenetic classifier for early stage lung cancer , 2018, Clinical Epigenetics.

[186]  M. Zhan,et al.  An integromic signature for lung cancer early detection , 2018, Oncotarget.

[187]  H. Ditzel,et al.  Correlation between circulating cell‐free PIK3CA tumor DNA levels and treatment response in patients with PIK3CA‐mutated metastatic breast cancer , 2018, Molecular oncology.

[188]  Joey Lai,et al.  Ultra-Sensitive Droplet Digital PCR for the Assessment of Microchimerism in Cellular Therapies. , 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[189]  P. Guldberg,et al.  Noninvasive Detection of High Grade Prostate Cancer by DNA Methylation Analysis of Urine Cells Captured by Microfiltration , 2018, The Journal of urology.

[190]  N. López-Bigas,et al.  Molecular Diagnosis of Diffuse Gliomas through Sequencing of Cell-Free Circulating Tumor DNA from Cerebrospinal Fluid , 2018, Clinical Cancer Research.

[191]  M. Huibers,et al.  The use of droplet digital PCR in liquid biopsies: A highly sensitive technique for MYD88 p.(L265P) detection in cerebrospinal fluid , 2018, Hematological oncology.

[192]  J. Joo,et al.  Prognostic Implications of Multiplex Detection of KRAS Mutations in Cell-Free DNA from Patients with Pancreatic Ductal Adenocarcinoma. , 2018, Clinical chemistry.

[193]  C. Paweletz,et al.  False-Positive Plasma Genotyping Due to Clonal Hematopoiesis , 2018, Clinical Cancer Research.

[194]  Jie Ma,et al.  Increased H. pylori stool shedding and EPIYA-D cagA alleles are associated with gastric cancer in an East Asian hospital , 2018, bioRxiv.

[195]  K. D. Sørensen,et al.  Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsies , 2018, Molecular oncology.

[196]  J. Lindebjerg,et al.  Monitoring the effect of first line treatment in RAS/RAF mutated metastatic colorectal cancer by serial analysis of tumor specific DNA in plasma , 2018, Journal of experimental & clinical cancer research : CR.

[197]  I. Wistuba,et al.  Salvaging the supernatant: next generation cytopathology for solid tumor mutation profiling , 2018, Modern Pathology.

[198]  Y. Kondo,et al.  A novel high-sensitivity assay to detect a small fraction of mutant IDH1 using droplet digital PCR , 2018, Brain Tumor Pathology.

[199]  Guofang Zhao,et al.  Urinary circulating DNA profiling in non-small cell lung cancer patients following treatment shows prognostic potential. , 2018, Journal of thoracic disease.

[200]  D. Zurakowski,et al.  Causal somatic mutations in urine DNA from persons with the CLOVES subgroup of the PIK3CA‐related overgrowth spectrum , 2018, Clinical genetics.

[201]  M. Zeegers,et al.  Toward Personalised Liquid Biopsies for Urothelial Carcinoma: Characterisation of ddPCR and Urinary cfDNA for the Detection of the TERT 228 G>A/T Mutation , 2018, Bladder cancer.

[202]  T. Harkins,et al.  Applying Precision Medicine to Ovarian Cancer , 2018, International Journal of Gynecologic Cancer.

[203]  L. Biesecker,et al.  Urine cell-free DNA is a biomarker for nephroblastomatosis or Wilms Tumor in PIK3CA-related overgrowth spectrum (PROS) , 2018, Genetics in Medicine.

[204]  J. Vandesompele,et al.  Prognostic and Therapeutic Implications of Circulating Androgen Receptor Gene Copy Number in Prostate Cancer Patients Using Droplet Digital Polymerase Chain Reaction , 2017, Clinical genitourinary cancer.

[205]  M. Goggins,et al.  The Effect of Pancreatic Juice Collection Time on the Detection of KRAS Mutations , 2017, Pancreas.

[206]  N. Dhomen,et al.  Circulating tumor DNA predicts survival in patients with resected high-risk stage II/III melanoma , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[207]  K. Birkenkamp-Demtröder,et al.  Re: Monitoring Treatment Response and Metastatic Relapse in Advanced Bladder Cancer by Liquid Biopsy Analysis. , 2019, The Journal of urology.

[208]  Yoon‐Kyoung Cho,et al.  Urine-based liquid biopsy: non-invasive and sensitive AR-V7 detection in urinary EVs from patients with prostate cancer. , 2018, Lab on a chip.

[209]  S Hanash,et al.  Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[210]  N. Normanno,et al.  RAS testing of liquid biopsy correlates with the outcome of metastatic colorectal cancer patients treated with first-line FOLFIRI plus cetuximab in the CAPRI-GOIM trial , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[211]  M. Goggins,et al.  Using an endoscopic distal cap to collect pancreatic fluid from the ampulla (with video). , 2017, Gastrointestinal endoscopy.

[212]  J. Ruland,et al.  AR-V7 in Peripheral Whole Blood of Patients with Castration-resistant Prostate Cancer: Association with Treatment-specific Outcome Under Abiraterone and Enzalutamide. , 2017, European urology.

[213]  D. García-Olmo,et al.  Detection of KRAS G12D in colorectal cancer stool by droplet digital PCR , 2017, World journal of gastroenterology.

[214]  F. Meric-Bernstam,et al.  Liquid Biopsies Using Plasma Exosomal Nucleic Acids and Plasma Cell-Free DNA 1 compared with Clinical Outcomes of Patients with Advanced Cancers , " 2 3 , 2017 .

[215]  A. Bardelli,et al.  Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases , 2017, ESMO Open.

[216]  D. García-Olmo,et al.  Current and Emerging Applications of Droplet Digital PCR in Oncology , 2017, Molecular Diagnosis & Therapy.

[217]  Subra Suresh,et al.  Isolation of exosomes from whole blood by integrating acoustics and microfluidics , 2017, Proceedings of the National Academy of Sciences.

[218]  H. Vogel,et al.  A pilot study on the use of cerebrospinal fluid cell-free DNA in intramedullary spinal ependymoma , 2017, Journal of Neuro-Oncology.

[219]  L. Lacroix,et al.  Crystal digital droplet PCR for detection and quantification of circulating EGFR sensitizing and resistance mutations in advanced non-small cell lung cancer , 2017, PloS one.

[220]  E. Vasile,et al.  Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer , 2017, Scientific Reports.

[221]  Nina Tunariu,et al.  Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory metastatic colorectal cancer patients in a prospective phase II study , 2017, Gut.

[222]  Chuanhao Tang,et al.  Droplet digital PCR improved the EGFR mutation diagnosis with pleural fluid samples in non-small-cell lung cancer patients. , 2017, Clinica chimica acta; international journal of clinical chemistry.

[223]  Yan-juan Zhu,et al.  Association of mutant EGFR L858R and exon 19 concentration in circulating cell-free DNA using droplet digital PCR with response to EGFR-TKIs in NSCLC. , 2017, Oncology letters.

[224]  J. Duyster,et al.  Early mixed hematopoietic chimerism detection by digital droplet PCR in patients undergoing gender-mismatched hematopoietic stem cell transplantation , 2017, Clinical chemistry and laboratory medicine.

[225]  Yan Li,et al.  Quantitative cell-free circulating EGFR mutation concentration is correlated with tumor burden in advanced NSCLC patients. , 2017, Lung cancer.

[226]  Yingyi Wang,et al.  Dynamic monitoring of EGFR mutations in circulating cell-free DNA for EGFR-mutant metastatic patients with lung cancer: Early detection of drug resistance and prognostic significance. , 2017, Oncology letters.

[227]  T. Ørntoft,et al.  Liquid Biopsy Analysis of FGFR3 and PIK3CA Hotspot Mutations for Disease Surveillance in Bladder Cancer. , 2017, European urology.

[228]  A. Camargo,et al.  Sequential liquid biopsies reveal dynamic alterations of EGFR driver mutations and indicate EGFR amplification as a new mechanism of resistance to osimertinib in NSCLC. , 2017, Lung cancer.

[229]  P. Laurent-Puig,et al.  Circulating Tumor DNA Measurement by Picoliter Droplet-Based Digital PCR and Vemurafenib Plasma Concentrations in Patients with Advanced BRAF-Mutated Melanoma , 2017, Targeted Oncology.

[230]  Xianjun Yu,et al.  Analysis of ctDNA to predict prognosis and monitor treatment responses in metastatic pancreatic cancer patients , 2017, International journal of cancer.

[231]  D. Amadori,et al.  Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[232]  J. Beaulieu,et al.  Droplet digital PCR for quantification of ITGA6 in a stool mRNA assay for the detection of colorectal cancers , 2017, World journal of gastroenterology.

[233]  Amar S Basu,et al.  Digital Assays Part I: Partitioning Statistics and Digital PCR , 2017, SLAS technology.

[234]  F. Jiang,et al.  A prediction model for distinguishing lung squamous cell carcinoma from adenocarcinoma , 2017, Oncotarget.

[235]  E. Soilleux,et al.  Validating a fully automated real-time PCR-based system for use in the molecular diagnostic analysis of colorectal carcinoma: a comparison with NGS and IHC , 2017, Journal of Clinical Pathology.

[236]  A. Bardelli,et al.  Integrating liquid biopsies into the management of cancer , 2017, Nature Reviews Clinical Oncology.

[237]  G. Hortobagyi,et al.  Correlation between PIK3CA mutations in cell-free DNA and everolimus efficacy in HR+, HER2− advanced breast cancer: results from BOLERO-2 , 2017, British Journal of Cancer.

[238]  J. Banfield,et al.  Disturbances of the Perioperative Microbiome Across Multiple Body Sites in Patients Undergoing Pancreaticoduodenectomy , 2017, Pancreas.

[239]  Mutsa P. Seremwe,et al.  A Comparative Study of Serum Exosome Isolation Using Differential Ultracentrifugation and Three Commercial Reagents , 2017, PloS one.

[240]  M. Oka,et al.  Highly sensitive stool DNA testing of Fusobacterium nucleatum as a marker for detection of colorectal tumours in a Japanese population , 2017, Annals of clinical biochemistry.

[241]  A. Talhouk,et al.  FOXL2 402C>G Mutation Can Be Identified in the Circulating Tumor DNA of Patients with Adult-Type Granulosa Cell Tumor. , 2017, The Journal of molecular diagnostics : JMD.

[242]  J. Madic,et al.  Three-color crystal digital PCR , 2016, Biomolecular detection and quantification.

[243]  F. Fang,et al.  Quantitative Detection and Genotyping of Helicobacter pylori from Stool using Droplet Digital PCR Reveals Variation in Bacterial Loads that Correlates with cagA Virulence Gene Carriage , 2016, Helicobacter.

[244]  Christopher M. Hindson,et al.  Absolute quantification by droplet digital PCR versus analog real-time PCR , 2013, Nature Methods.

[245]  Tania Nolan,et al.  The digital MIQE guidelines: Minimum Information for Publication of Quantitative Digital PCR Experiments. , 2013, Clinical chemistry.

[246]  Charles N. Baroud,et al.  Droplet microfluidics driven by gradients of confinement , 2013, Proceedings of the National Academy of Sciences.

[247]  Jeff Mellen,et al.  High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy Number , 2011, Analytical chemistry.